IN8BIO, Inc.
INAB· Nasdaq
INABIN8BIO, Inc.
Filed May 12, 2022 · 10-Q · 42 days after period end · 0000950170-22-009658
| Metric | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|
| Net Income | -$6.15M | -$2.36M | -$1.69M |
| EPS Diluted | -$0.33 | -$0.82 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
IN8BIO, Inc. · CIK 1740279 · Engraved from SEC EDGAR
ended Mar 31, 2022 · filed May 12, 2022 · 42 d after period end
